EPISODE · Jul 1, 2025 · 14 MIN
Breakthroughs in Immunotherapy for Colorectal Cancer: Hope for Targeted and Lasting Results
In this episode, we explore how immunotherapy is changing the future of colorectal cancer treatment, offering powerful, targeted solutions for patients who haven’t responded to chemotherapy or want fewer side effects.You’ll learn:How immunotherapy uses the body’s immune system to detect and destroy cancer cellsWhy early treatment with immunotherapy can slow or stop disease progressionHow genetic markers like dMMR, Lynch syndrome, and TMB impact treatment successThe most effective immunotherapy types for colorectal cancer: checkpoint inhibitors, cytokine therapy, and cancer vaccinesWhy immunotherapy is often easier on the body than chemotherapyHow long-term immune “memory” can protect against cancer recurrenceWhether you’re newly diagnosed or exploring advanced treatment options, this episode reveals why immunotherapy offers real hope for a healthier future.Blog Link: Immunotherapy for Colorectal CancerSend us Fan MailThank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.Author: Dr. CHRISTINA NG VAN TZE📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
What this episode covers
In this episode, we explore how immunotherapy is changing the future of colorectal cancer treatment, offering powerful, targeted solutions for patients who haven’t responded to chemotherapy or want fewer side effects. You’ll learn: How immunotherapy uses the body’s immune system to detect and destroy cancer cellsWhy early treatment with immunotherapy can slow or stop disease progressionHow genetic markers like dMMR, Lynch syndrome, and TMB impact treatment successThe most effective immunother...
NOW PLAYING
Breakthroughs in Immunotherapy for Colorectal Cancer: Hope for Targeted and Lasting Results
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m